Pharmacologic Induction of Tolerance for Hypoxia & Hypothermia
Sponsor: United States Department of Defense
This observational or N/A phase trial investigates Hypothermia and Hypoxia and is currently ongoing. United States Department of Defense leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2025 — Feb 2026 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Feb 2025 [monthly]
Not Yet Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
▶ Show 2 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Not Yet Recruiting
-
Dec 2023 — Feb 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- United States Department of Defense
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .